Inherent Biosciences, Inc.
Publicly observedSalt Lake City, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Salt Lake City | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Inherent Biosciences, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | X9LJM6ADLJV7 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Sept 2026Publicly observed
NIH SBIR/STTR award: Epigenetic Diagnostic for Severe Spermatogenic Failure and Associated Malignancy Risks
USD 1,167,156.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
- Grant5 Feb 2024Publicly observed
NIH SBIR/STTR award: Novel Epigenetic Test for the Treatment and Improvement of Longitudinal Health-Outcomes for Men with Severe Infertility
USD 50,000.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
- Grant5 Feb 2024Publicly observed
NIH SBIR/STTR award: Novel Epigenetic Test for the Treatment and Improvement of Longitudinal Health-Outcomes for Men with Severe Infertility
USD 804,660.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.